The global pharmaceutical processing seals market size was estimated at USD 2.52 billion in 2023 and is expected to grow at a CAGR of 10.2% from 2024 to 2030. This growth is attributed to the presence of stringent regulations relating to pharmaceutical manufacturing. For instance, regulatory agencies such as the FDA (in the U.S.), EMA (in Europe), and similar bodies worldwide enforce stringent standards for pharmaceutical manufacturing. This drives the demand for seals that comply with these regulations to ensure product safety and quality, thereby, positively impacting market growth.
The global demand for pharmaceutical products continues to rise due to population growth, aging demographics, and increasing prevalence of chronic diseases. This drives expansion in pharmaceutical manufacturing facilities, boosting the demand for sealing solutions to maintain hygienic and sterile conditions. Furthermore, shift towards biopharmaceuticals, including vaccines, antibodies, and gene therapies, requires specialized sealing solutions due to the sensitive nature of biologics. Seals play a crucial role in maintaining the integrity and efficacy of these products, thereby driving the pharmaceutical processing seals market growth.
Continuous advancements in sealing technologies, such as the development of materials with improved chemical resistance, durability, and sealing performance, enhance the efficiency and reliability of pharmaceutical manufacturing processes. This encourages adoption and drives market expansion. Moreover, there is a growing emphasis on patient safety and product quality in pharmaceutical manufacturing. Seals prevent contamination and ensure product sterility, contributing to enhanced safety standards and reducing the risk of adverse events.
Seals made from advanced materials such as PTFE (Polytetrafluoroethylene), Viton (fluoroelastomer), and silicone can be expensive. This cost factor may prevent smaller pharmaceutical companies from investing in high-performance sealing solutions. In addition to this, seals must be compatible with a wide range of pharmaceutical formulations, including liquids, powders, and biologics. This further provides rules for pharmaceutical processing seals manufacturers.
Metal dominated the market and accounted for a revenue share of 35.2% in 2023. Metals are primarily used in pharmaceutical processing seals for their durability, strength, and resistance to corrosion. Common metals used for manufacturing sealing solutions include stainless steel, aluminum, and titanium. They are commonly used for seals in pumps, valves, and fittings where robust sealing is required.
Rubber materials are elastomers known for their flexibility, resilience, and sealing properties. Common rubber materials used in product manufacturing include EPDM and silicone rubber. It is used in seals for outdoor equipment and steam sterilization applications in pharmaceutical processing. Furthermore, silicone materials offer unique properties that make them suitable for this product manufacturing such as high temperature resistance, flexibility, elasticity, and biocompatibility.
The O-rings segment accounted for the largest revenue share of 33.0% in 2023 and is further expected to grow at the fastest CAGR of 10.8% over forecast period. O-rings are used in pharmaceutical processing equipment for sealing static and dynamic applications where relative motion occurs, such as pumps, valves, and connectors. They offer excellent sealing properties, resilience, and resistance to a wide range of chemicals and temperatures, ensuring reliable performance in pharmaceutical environments.
Gaskets are expected to witness growth at second fastest rate over the forecast period. Gaskets are flat seals used to create a static seal between two surfaces, often made from flexible materials like silicone rubber, EPDM, Viton, and PTFE (Polytetrafluoroethylene). They provide reliable sealing under compression, resist chemicals, and maintain their integrity over a wide range of temperatures and pressures. On the other hand, lip seals offer effective sealing against liquids and gases, even at high speeds and pressures, ensuring operational reliability in pharmaceutical manufacturing.
North America is expected to grow at a significant rate over the forecast period. Rising healthcare expenditure in North America supports continuous investment in pharmaceutical manufacturing infrastructure, including sealing solutions. This expenditure is driven by an aging population, higher prevalence of chronic diseases, and increasing demand for pharmaceutical products.
The market in the U.S. is expected to grow at a CAGR of 9.4% over the forecast period. Country is at the forefront of technological advancements in pharmaceutical processing. This includes the adoption of advanced sealing technologies that enhance efficiency, reduce contamination risks, and comply with stringent regulatory requirements. Furthermore, country has stringent regulatory standards for pharmaceutical manufacturing, including the use of seals that comply with FDA (Food and Drug Administration) and Health Canada guidelines. This drives the demand for high-quality, compliant sealing solutions.
Europe has a well-established pharmaceutical industry known for its high standards of manufacturing and compliance with regulatory requirements. This demands reliable sealing solutions to ensure product safety, integrity, and adherence to EU regulations. In addition to this, Europe has stringent environmental regulations that impact pharmaceutical manufacturing processes, including the choice of sealing materials. Sustainable and compliant sealing solutions are gaining traction in region.
Asia Pacific dominated the market in 2023 with a revenue share of 47.7%. Asia Pacific is witnessing rapid growth in pharmaceutical manufacturing, driven by increasing healthcare expenditure, rising population, and expanding middle-class population with higher healthcare expectations. Countries like China, India, and Japan are key contributors in growth of pharmaceutical manufacturing, thereby, positively affecting product growth. Furthermore, Asia Pacific countries are increasingly focusing on pharmaceutical research and development, including the development of generic drugs and biopharmaceuticals. This drives demand for seals that support advanced manufacturing processes and product innovation.
Some of the key players operating in the market include Flowserve Corporation and Saint-Gobain S.A. among others:
Flowserve Corporation, founded in 1997 and headquartered in Irving, Texas, USA, is a manufacturers of fluid motion and control products and services. The company specializes in designing, manufacturing, and servicing of pumps, valves, seals, and related equipment for various industrial applications.
Saint-Gobain S.A. is a France based company established in 1665. It is engaged in the design, manufacturing, and distribution of high-performance materials and building materials. In addition, it provides solutions for energy efficiency, growth challenges, and protection of the environment.
IDEX Corporation and Parker Hannifin Corporation are some of the emerging participants in the market.
IDEX Corporation was established in 1988 and its business segments includes fluid & metering technologies, health & science technologies, and fire & safety/diversified products. It operates manufacturing facilities in around 20 countries serving various industries such as aerospace, agriculture, automotive, dispensing, medical, life science, food & pharma, energy, industrial, among others.
Parker Hannifin Corporation is involved in manufacturing of sealing solutions and high performance materials. Its products find applications in many industries such as diabetes care, surgical, respiratory, pharmaceutical, drug delivery, thermal management, and shielding management.
The following are the leading companies in the pharmaceutical processing seals market. These companies collectively hold the largest market share and dictate industry trends.
In November 2023, Pharmaceutical Services, Inc. (West), a company involved in manufacturing of healthcare and injectable drug products, launched its Gamma Irradiated Flip-Off seals product in India and other Asia pacific countries. This product is developed and designed to deliver safe and convenient user experience while maintaining consistency and container closure integrity. It will help biopharmaceutical and pharmaceutical manufacturers to protect their products and maintain drug quality.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.74 billion |
Revenue forecast in 2030 |
USD 5.40 billion |
Growth rate |
CAGR of 10.2% from 2023 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
Segments covered |
Material, product, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Argentina |
Key companies profiled |
Flowserve Corporation; Morgan Advanced Materials PLC; Trelleborg AB; Garlock; Saint-Gobain S.A.; Parker Hannifin Corporation; IDEX Corporation; James Walker; Freudenberg Group; John Crane |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional & country levels and provides an analysis of the industry trends in each of the segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical processing seals market report based on material, product, and region:
Material Outlook (Revenue, USD Million, 2018 - 2030)
Metal
Rubber
Silicone
Polymer/Elastomer
Other Materials
Product Outlook (Revenue, USD Million, 2018 - 2030)
O-rings
Gaskets
Lip Seals
D Seals
Other Products
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Central & South America
Brazil
Argentina
Middle East & Africa
b. The global pharmaceutical processing seals market size was estimated at USD 2.52 billion in 2023 and is expected to reach USD 2.74 billion in 2024.
b. The global pharmaceutical processing seals market is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2030 to reach USD 5.40 billion by 2030.
b. O-rings accounted for the largest pharmaceutical processing seals market share of 33.0% in 2023 as they offer excellent sealing properties, resilience, and resistance to a wide range of chemicals and temperatures, ensuring reliable performance in pharmaceutical environments.
b. Some key players operating in the pharmaceutical processing seals market include Flowserve Corporation, Morgan Advanced Materials PLC, Trelleborg AB, Garlock, Saint-Gobain S.A., Parker Hannifin Corporation, IDEX Corporation, James Walker, Freudenberg Group, and John Crane.
b. The key factors that are driving the pharmaceutical processing seals market growth is the presence of stringent regulations relating to pharmaceutical manufacturing driving demand for high quality sealing solutions.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."